Shivangi Mishra1, Megha Neolia1, Sherya Patil1, Amit Kumar Tyagi2 and Jai Prakash Muyal1*
1School of Biotechnology, Gautam Buddha University (GBU), Gautam Budh Nagar, Uttar Pradesh, India
2Nuclear Medicine Department, Institute of Nuclear Medicine and Allied Sciences, Defence Research Development Organization, New Delhi, India
*Corresponding Author: Jai Prakash Muyal, School of Biotechnology, Gautam Buddha University (GBU), Gautam Budh Nagar, Uttar Pradesh, India.
Received: August 05, 2020; Published: August 19, 2020
Pulmonary emphysema is principally associated with the lung. The inflammation is the main cause of emphysema that triggers release of inflammatory mediators. Such inflammatory mediators might get spilled out from the lung to the proximal and distal organs, hence may affects other organ’s functioning as well. In this light, firstly, we attempted to determine the spillage of inflammatory mediators on liver and heart organs of emphysematous lung mice model. Secondly, to elucidate the beneficial role of ATRA+VEGF supplementation towards such spillage of inflammatory mediators by studying the antioxidant levels, which leads in tissue damage and hence affects its function.
To analyse these two objectives, in silico study has been performed for the prediction of the gene interaction network between elastase, ATRA, and VEGF, respectively with extracellular regulated kinases (ERK) pathway. Furthermore, antioxidant levels and histopathology were studied in before elastase-treatment, after elastase-treatment and after elastase-treated group received ATRA+VEGF conditions using liver and heart tissues.
Elastase-treated group received ATRA+VEGF has proven to be beneficial in reducing inflammation as the levels of anti-oxidants was significantly reduced. Moreover, the tissue architecture of liver and heart was improved due to the ATRA+VEGF supplementation. At last, gene interaction network results provide a promising role of ATRA and VEGF in rectification of inflammation via involvement of spilled out inflammatory mediators. However, an elaborate experimental study is further required to investigate the beneficial role of ATRA+VEGF therapy on ERK pathway towards amelioration of inflammation.
Keywords: ATRA+VEGF Therapy; Organs; Chronic Obstructive Pulmonary Disease (COPD)
Citation: Jai Prakash Muyal., et al. “Effects of a Combined Therapy of ATRA+VEGF on Distal Organs of Emphysematous Mice Model". Acta Scientific Medical Sciences 4.9 (2020): 38-45.
Copyright: © 2020 Jai Prakash Muyal., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.